Sanofi looking to expand India hub with Rs 3.6k-cr push
French drugmaker Sanofi plans to invest ₹400 million (about ₹3,600 crore) over the next six years to expand its global capability centre (GCC) in Hyderabad by increasing the headcount and further developing the facility. Of the total, ₹100 million will be invested by the end of 2025. Over the next two years, Sanofi plans to more than double the headcount at the Hyderabad GCC to 2,600 employees, making the centre the largest of its four hubs globally. The company employs about 1,000 people in Hyderabad.
The Hyderabad GCC will support Sanofi's global operations spanning commercial, manufacturing, supply chain research and development (R&D) and digitalisation.
The GCC in India will help the company bring some of outsourced functions in-house, giving it more control over critical operations like manufacturing, commercial and R&D.
Established in 2019, Sanofi's Hyderabad GCC is a relatively late entrant to multinational corporations setting up GCCs in India. But, the last one year, the company doubled its headcount in Hyderabad, and expanded from being a medical affairs hub to one providing several best-in-class services to Sanofi's global functions and affiliates across the world.
The Hyderabad GCC gained significance as Sanofi undertook massive review to centralise and simplify global operations, allowing the company to redirect resources towards more successful therapeutic areas such as immunology.
«We have taken a decision last year, as our next chapter of 'play to win' to double down on building centralised
